28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The HIV-1 transmission bottleneck

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          It is well established that most new systemic infections of HIV-1 can be traced back to one or a limited number of founder viruses. Usually, these founders are more closely related to minor HIV-1 populations in the blood of the presumed donor than to more abundant lineages. This has led to the widely accepted idea that transmission selects for viral characteristics that facilitate crossing the mucosal barrier of the recipient’s genital tract, although the specific selective forces or advantages are not completely defined. However, there are other steps along the way to becoming a founder virus at which selection may occur. These steps include the transition from the donor’s general circulation to the genital tract compartment, survival within the transmission fluid, and establishment of a nascent stable local infection in the recipient’s genital tract. Finally, there is the possibility that important narrowing events may also occur during establishment of systemic infection. This is suggested by the surprising observation that the number of founder viruses detected after transmission in intravenous drug users is also limited. Although some of these steps may be heavily selective, others may result mostly in a stochastic narrowing of the available founder pool. Collectively, they shape the initial infection in each recipient.

          Related collections

          Most cited references207

          • Record: found
          • Abstract: found
          • Article: not found

          Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

          Human cells possess an antiviral activity that inhibits the release of retrovirus particles, and other enveloped virus particles, and is antagonized by the HIV-1 accessory protein, Vpu. This antiviral activity can be constitutively expressed or induced by interferon-alpha, and it consists of protein-based tethers, which we term 'tetherins', that cause retention of fully formed virions on infected cell surfaces. Using deductive constraints and gene expression analyses, we identify CD317 (also called BST2 or HM1.24), a membrane protein of previously unknown function, as a tetherin. Specifically, CD317 expression correlated with, and induced, a requirement for Vpu during HIV-1 and murine leukaemia virus particle release. Furthermore, in cells where HIV-1 virion release requires Vpu expression, depletion of CD317 abolished this requirement. CD317 caused retention of virions on cell surfaces and, after endocytosis, in CD317-positive compartments. Vpu co-localized with CD317 and inhibited these effects. Inhibition of Vpu function and consequent mobilization of tetherin's antiviral activity is a potential therapeutic strategy in HIV/AIDS.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

            Treatment of infected patients with ABT-538, an inhibitor of the protease of human immunodeficiency virus type 1 (HIV-1), causes plasma HIV-1 levels to decrease exponentially (mean half-life, 2.1 +/- 0.4 days) and CD4 lymphocyte counts to rise substantially. Minimum estimates of HIV-1 production and clearance and of CD4 lymphocyte turnover indicate that replication of HIV-1 in vivo is continuous and highly productive, driving the rapid turnover of CD4 lymphocytes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.

              Contact between dendritic cells (DC) and resting T cells is essential to initiate a primary immune response. Here, we demonstrate that ICAM-3 expressed by resting T cells is important in this first contact with DC. We discovered that instead of the common ICAM-3 receptors LFA-1 and alphaDbeta2, a novel DC-specific C-type lectin, DC-SIGN, binds ICAM-3 with high affinity. DC-SIGN, which is abundantly expressed by DC both in vitro and in vivo, mediates transient adhesion with T cells. Since antibodies against DC-SIGN inhibit DC-induced proliferation of resting T cells, our findings predict that DC-SIGN enables T cell receptor engagement by stabilization of the DC-T cell contact zone.
                Bookmark

                Author and article information

                Contributors
                sam_ndia@yahoo.com
                philippe.selhorst@uct.ac.za
                karien@itg.be
                jeffrey.dorfman@uct.ac.za
                Journal
                Retrovirology
                Retrovirology
                Retrovirology
                BioMed Central (London )
                1742-4690
                23 March 2017
                23 March 2017
                2017
                : 14
                : 22
                Affiliations
                [1 ]ISNI 0000 0004 1937 1151, GRID grid.7836.a, Division of Immunology, Department of Pathology, Falmouth 3.25, , University of Cape Town, ; Anzio Rd, Observatory, Cape Town, 7925 South Africa
                [2 ]ISNI 0000 0004 1937 1151, GRID grid.7836.a, Division of Medical Virology, Department of Pathology, , University of Cape Town, ; Cape Town, South Africa
                [3 ]GRID grid.443877.b, , International Centre for Genetic Engineering and Biotechnology, ; Cape Town, South Africa
                [4 ]GRID grid.449670.8, Department of Biological Sciences, , University of Eldoret, ; Eldoret, Kenya
                [5 ]ISNI 0000 0001 2153 5088, GRID grid.11505.30, Virology Unit, Department of Biomedical Sciences, , Institute of Tropical Medicine, ; Antwerp, Belgium
                [6 ]ISNI 0000 0001 0790 3681, GRID grid.5284.b, Department of Biomedical Sciences, , University of Antwerp, ; Antwerp, Belgium
                Author information
                http://orcid.org/0000-0001-9938-8911
                Article
                343
                10.1186/s12977-017-0343-8
                5364581
                28335782
                8e118829-7eec-4cf7-8822-cc6e893bd1d5
                © The Author(s) 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 4 January 2017
                : 5 March 2017
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001321, National Research Foundation;
                Award ID: 104661
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001323, Poliomyelitis Research Foundation;
                Award ID: 15/09
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001688, International Centre for Genetic Engineering and Biotechnology;
                Award ID: PhD Bursary
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100003130, Fonds Wetenschappelijk Onderzoek;
                Award ID: Multiple
                Award Recipient :
                Categories
                Commentary
                Custom metadata
                © The Author(s) 2017

                Microbiology & Virology
                hiv-1,transmission,bottleneck,genital mucosa,intravenous drug user
                Microbiology & Virology
                hiv-1, transmission, bottleneck, genital mucosa, intravenous drug user

                Comments

                Comment on this article